These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30788973)

  • 21. Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches.
    Seipelt RG; Franke A; Vazquez-Jimenez JF; Hanrath P; von Bernuth G; Messmer BJ; Mühler EG
    Ann Thorac Surg; 2002 Aug; 74(2):556-62. PubMed ID: 12173844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.
    Monagle P; Cochrane A; Roberts R; Manlhiot C; Weintraub R; Szechtman B; Hughes M; Andrew M; McCrindle BW;
    J Am Coll Cardiol; 2011 Aug; 58(6):645-51. PubMed ID: 21798429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic therapy after mitral valve repair: VKA or aspirin?
    van der Wall SJ; Olsthoorn JR; Heuts S; Klautz RJM; Tomsic A; Jansen EK; Vonk ABA; Sardari Nia P; Klok FA; Huisman MV
    J Thromb Thrombolysis; 2018 Nov; 46(4):473-481. PubMed ID: 30132244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics.
    Ohuchi H; Yasuda K; Miyazaki A; Ono S; Hayama Y; Negishi J; Noritake K; Mizuno M; Yamada O
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):511-9. PubMed ID: 24699205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboembolic Complications in Adult Patients Following Fontan Procedure-A Multicenter Study.
    Skubera M; Gołąb A; Sternalski T; Trojnarska O; Plicner D; Smaś-Suska M; Mazurek-Kula A; Bartczak-Rutkowska A; Pająk J; Podolec P; Tomkiewicz-Pająk L
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombotic therapy practices in US hospitals in an era of practice guidelines.
    Tapson VF; Hyers TM; Waldo AL; Ballard DJ; Becker RC; Caprini JA; Khetan R; Wittkowsky AK; Colgan KJ; Shillington AC;
    Arch Intern Med; 2005 Jul; 165(13):1458-64. PubMed ID: 16009860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience.
    Lee SI; Lee KS; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH
    Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):128-134. PubMed ID: 28367855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
    van der Wall SJ; Umans VA; Schotten J; Keijzers M; Wolterbeek R; Jansen EK; Huisman MV; Vonk AB
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1157-63. PubMed ID: 26233944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboprophylaxis strategies for children with single-ventricle circulations (superior or total cavo-pulmonary connections) after stent implantation.
    Ooi YK; Ligon RA; Kelleman M; Vincent RN; Bauser-Heaton HD; Kim DW; Petit CJ
    Cardiol Young; 2019 Jul; 29(7):877-884. PubMed ID: 31208476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients.
    Faircloth JM; Miner KM; Alsaied T; Nelson N; Ciambarella J; Mizuno T; Palumbo JS; Vinks AA; Veldtman GR
    J Thromb Thrombolysis; 2017 Jul; 44(1):38-47. PubMed ID: 28429248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-Five Year Outcomes of the Lateral Tunnel Fontan Procedure.
    Wilson TG; Shi WY; Iyengar AJ; Winlaw DS; Cordina RL; Wheaton GR; Bullock A; Gentles TL; Weintraub RG; Justo RN; Grigg LE; Radford DJ; d'Udekem Y;
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):347-353. PubMed ID: 29195575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The extracardiac conduit Fontan procedure in Australia and New Zealand: hypoplastic left heart syndrome predicts worse early and late outcomes.
    Iyengar AJ; Winlaw DS; Galati JC; Wheaton GR; Gentles TL; Grigg LE; Justo RN; Radford DJ; Weintraub RG; Bullock A; Celermajer DS; d'Udekem Y;
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):465-73; discussion 473. PubMed ID: 24578409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could DOAC Be a Better Choice Than Warfarin in Low Compliance Patients with Fontan Procedure?
    Park J; Hong BY; Kim JS; Park JG; Jung J; Lim SH
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068569
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
    Gherli T; Colli A; Fragnito C; Nicolini F; Borrello B; Saccani S; D'Amico R; Beghi C
    Circulation; 2004 Aug; 110(5):496-500. PubMed ID: 15289387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
    Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
    Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Gao F; Zhou YJ; Wang ZJ; Shen H; Liu XL; Nie B; Yan ZX; Yang SW; Jia de A; Yu M
    Circ J; 2010 Apr; 74(4):701-8. PubMed ID: 20208381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.